Zheng, X.; Wezel, F.; Azoitei, A.; Meessen, S.; Wang, W.; Najjar, G.; Wang, X.; Kraus, J.M.; Kestler, H.A.; John, A.;
et al. Shorter Leukocyte Telomere Length Is Associated with Worse Survival of Patients with Bladder Cancer and Renal Cell Carcinoma. Cancers 2021, 13, 3774.
https://doi.org/10.3390/cancers13153774
AMA Style
Zheng X, Wezel F, Azoitei A, Meessen S, Wang W, Najjar G, Wang X, Kraus JM, Kestler HA, John A,
et al. Shorter Leukocyte Telomere Length Is Associated with Worse Survival of Patients with Bladder Cancer and Renal Cell Carcinoma. Cancers. 2021; 13(15):3774.
https://doi.org/10.3390/cancers13153774
Chicago/Turabian Style
Zheng, Xi, Felix Wezel, Anca Azoitei, Sabine Meessen, Wenya Wang, Gregoire Najjar, Xue Wang, Johann M. Kraus, Hans A. Kestler, Axel John,
and et al. 2021. "Shorter Leukocyte Telomere Length Is Associated with Worse Survival of Patients with Bladder Cancer and Renal Cell Carcinoma" Cancers 13, no. 15: 3774.
https://doi.org/10.3390/cancers13153774
APA Style
Zheng, X., Wezel, F., Azoitei, A., Meessen, S., Wang, W., Najjar, G., Wang, X., Kraus, J. M., Kestler, H. A., John, A., Zengerling, F., Bolenz, C., & Günes, C.
(2021). Shorter Leukocyte Telomere Length Is Associated with Worse Survival of Patients with Bladder Cancer and Renal Cell Carcinoma. Cancers, 13(15), 3774.
https://doi.org/10.3390/cancers13153774